Genome Medicine (2023)Download PDF Sections Figures References Abstract Introduction Results Discussion Methods Data availability Code availability Abbreviations References Acknowledgements Author information Ethics declarations Additional information Supplementary Information Rights and permissions About this article This...
Use the filters below to search for a safety issue. Recalls: Search by the date of when a recall was published, and filter by product type. Note: The date range results are based on the date the recall was published. The date displayed with the recall is in reference to when the safet...
Receiver operating characteristic (ROC) curve was used to analyze the predictive value of cranial magnetic resonance G/P value combined with serum TSB and NSE for ABE occurrence in severe NHB. Results: The incidence of ABE in 369 children with NHB was 12.47% (46/369)...
NEOTORCH is the world’s first phase III clinical study of a anti-PD-1 monoclonal antibody for NSCLC perioperative treatment (including neoadjuvant and adjuvant) with positive EFS results. NEOTORCH’s latest study results were announced in an oral presentation at the 2023 American Society of Clini...